The successful candidate will break news on an industry that has suffered a major political loss in the United States and is bracing for new federal efforts to bring down the cost of prescription medicines.
This reporter would shed light on the commercial strategies of leading industry players, with a broad view on how new medicines in development will impact companies, investors, patients and providers.
At the same time, the candidate will report on how big pharma companies are turning to deals and new business opportunities after having benefited tremendously from developing vaccines and treatments critical to alleviating the COVID-19 pandemic.
The reporter would demonstrate a track record of deep source development and show how they would cultivate a roster of sources among pharmaceutical and biotech executives, government health officials and industry investors. The preferred location for the role is New York.
About the Role
As our U.S. Pharmaceutical Industry Reporter, you will:
About You
To be our U.S. Pharmaceutical Industry Reporter, you will likely have:
Please note, the deadline for applications is Friday 14th October 2022.
To apply, go here.
Fortune senior reporter Michael del Castillo is leaving the publication to start his own consulting and…
Bloomberg News is one of the biggest financial and business news organizations in the world.…
Politico reporter Louise Guillot is moving to its energy and climate team to cover European Union climate…
Jeremy Olshan, who is departing The Wall Street Journal where he has been personal finance…
Danish Mehboob has been hired as a senior distressed debt reporter at 9fin, where he…
Sara Paulson Meehan has been promoted to managing editor at Buffalo Business First. She has…